Medscape: HRT Tied to Increased Risk of Severe Asthma Exacerbation
UC allergist discusses hormone replacement therapy’s impact on asthmatic women
Jonathan Bernstein, MD, allergist and professor in the University of Cincinnati College of Medicine, weighs in on a study that suggests hormone replacement therapy may increase the risk of severe asthma in peri- and post-menopausal women.
Researchers say that starting around puberty, asthma becomes more common and severe in women than in men and that continues in women until around menopause. Sex hormones may partly explain the difference.
"It is clear that some women have worsening of a number of health issues peri-menstrual when there are estrogen and/or progesterone surges, including asthma, migraines, urticaria and hereditary angioedema, among other conditions,” Bernstein told a Reuters Health journalist for a story that appeared in Medscape.
Related Stories
WLWT: Tips to fight off bad allergy symptoms
April 18, 2024
The University of Cincinnati's Ahmad Sedaghat spoke with WLWT about how Cincinnati's geography tends to make allergy symptoms worse and tips to fight off those symptoms.
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
UC researchers develop new CPAP device
April 17, 2024
Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.